Abbott India Q2 profit rises 16% on higher sales, improved margins

Abbott India Ltd on Thursday (November 6) reported a 16% year-on-year rise in net profit to ₹415.3 crore for the quarter ended September 2025, compared with ₹359 crore in the same period last year, driven by steady revenue growth and stronger operating margins.

Revenue from operations grew 7.7% to ₹1,757 crore, up from ₹1,633 crore a year earlier, the company said in its exchange filing. The healthcare major’s EBITDA rose 14.5% to ₹502.6 crore from ₹439 crore in the corresponding quarter last year. Operating performance improved, with EBITDA margin expanding to 28.6%, compared with 26.9% in the same quarter last year.

The shares of the company are trading 1.6% in the green at 1:52 pm. The stock, however, has fallen 0.6% in the year so far.

In the first quarter of FY26, the company reported a 11.6% rise in net profit. The earnings before interest, taxes, depreciation and amortisation (EBITDA) jumped 14% to ₹445.7 crore in the April to June period. However, the EBITDA margins improved only slightly to 25.6% from 25.1% last year.

Catch live market updates with CNBC-TV18.com's blog